THE BRIDGE GROUP PRACTICE — All Prescriptions & Medications
Practice Code: B81046 | HULL, HU6 9BX
Over the last 12 months, THE BRIDGE GROUP PRACTICE prescribed 249,846 items across 592 different medications at a total cost of £1,710,984 to the NHS. Below is the complete list of all medications prescribed, sorted by volume.
| Medication | Items (12m) ↑ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Rabeprazole sodium | 10 | 280 | £25 | -80.6% ▼ |
| Empagliflozin/metformin | 10 | 560 | £348 | -80.8% ▼ |
| Acetic acid | 10 | 50 | £47 | -13.7% ▼ |
| Menthol | 10 | 2,200 | £79 | -64.5% ▼ |
| Clindamycin/tretinoin | 10 | 330 | £125 | -14.8% ▼ |
| Ivermectin | 10 | 630 | £365 | -53.0% ▼ |
| Diclofenac sodium | 10 | 500 | £364 | -58.3% ▼ |
| 10 | 135 | £32 | -74.6% ▼ | |
| 10 | 560 | £21 | +173.3% ▲ | |
| 10 | 150 | £471 | +124.8% ▲ | |
| 10 | 110 | £303 | -79.1% ▼ | |
| 10 | 80 | £159 | -31.5% ▼ | |
| 10 | 1,200 | £134 | +49.5% ▲ | |
| 10 | 1,020 | £892 | -75.3% ▼ | |
| 10 | 200 | £1.4K | -21.1% ▼ | |
| Mometasone/glycopyrronium/indacaterol | 11 | 330 | £465 | -27.4% ▼ |
| Phentolamine/aviptadil | 11 | 55 | £523 | +54.1% ▲ |
| Bicalutamide | 11 | 308 | £20 | -66.0% ▼ |
| Tube feed 1.5 kcal/ml peptide based (0914032) | 11 | 345.0K | £7.8K | +14.7% ▲ |
| Azelastine hydrochloride | 11 | 88 | £67 | -7.5% ▼ |
| Ketoconazole | 11 | 360 | £48 | +10.6% ▲ |
| 11 | 184 | £868 | -46.4% ▼ | |
| 11 | 540 | £2.8K | -5.3% ▼ | |
| 11 | 160 | £788 | -10.2% ▼ | |
| Lisinopril with diuretic | 12 | 336 | £119 | -41.5% ▼ |
| Betamethasone sodium phosphate | 12 | 548 | £73 | -2.4% ▼ |
| Testosterone undecanoate | 12 | 12 | £1.0K | -52.7% ▼ |
| Sodium fluoride | 12 | 1,209 | £61 | -63.8% ▼ |
| Ascorbic acid | 12 | 168 | £216 | -41.6% ▼ |
| Vitamin E | 12 | 720 | £251 | +10.4% ▲ |
| Ready to serve infant formula, high energy (0913104) | 12 | 126.0K | £1.9K | +8.6% ▲ |
| Methocarbamol | 12 | 1,200 | £75 | -74.9% ▼ |
| 12 | 180 | £39 | +145.5% ▲ | |
| 12 | 720 | £793 | +175.0% ▲ | |
| 12 | 1,100 | £728 | +43.2% ▲ | |
| 12 | 442 | £256 | -37.9% ▼ | |
| 12 | 4,500 | £446 | -75.1% ▼ | |
| 12 | 420 | £1.3K | -1.5% vs avg | |
| 12 | 560 | £2.6K | +44.5% ▲ | |
| 12 | 540 | £1.2K | -15.2% ▼ | |
| 12 | 450 | £998 | +38.4% ▲ | |
| Glycopyrronium bromide | 13 | 3,060 | £3.9K | -36.7% ▼ |
| Balsalazide sodium | 13 | 2,184 | £487 | -12.7% ▼ |
| Co-amilofruse (Amiloride hydrochloride/frusemide) | 13 | 364 | £53 | -62.6% ▼ |
| Terazosin hydrochloride | 13 | 182 | £42 | -20.1% ▼ |
| Midodrine hydrochloride | 13 | 1,396 | £209 | -73.3% ▼ |
| INR blood testing reagents | 13 | 312 | £888 | +72.5% ▲ |
| Dabigatran etexilate | 13 | 780 | £606 | -74.9% ▼ |
| Indacaterol maleate | 13 | 390 | £398 | +49.8% ▲ |
| Roflumilast | 13 | 390 | £466 | -1.0% vs avg |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.